Express Next Day Delivery

Copy of the email letter sent to Rightangled's shareholders on the 25th of December 2021. 

"Dear Investors,

Merry Christmas! I hope this email finds you in good health. 

Welcome to your end-of-year (2021) newsletter. 

The second half of 2021 has been very promising, transitioning from being one of the busiest times for Rightangled so far into what seems to be a new chapter in Rightangled’s scale up journey. 

The past year has made plenty of room for growth and new opportunities, which we are excited to announce.

  • Turnover of + £17M in 2021 with an operating profit of nearly £4M
  • Investing in business assets. 
  • Acquisition of a commercial building at 32 Galena Road, Hammersmith, London. Our new HQ consists of 3 floors spanning 4178 sqft. 
  • Acquisition of domain name - the transition from our current '.co' suffix to '.com' will provide easier access to international markets and solidify the company’s market positioning. 
  • Dispatched over half a million tests, reaching the highest selling point in July/August last summer.
  • We quadrupled the number of customers and B2B clients, delivering in the entire United Kingdom and opening same-day courier service in London (within the M25).
  • We are now transitioning back into increasing demand for our Blood and DNA Test, aiming to deliver nationwide through cross and up sales, directly managed from the users portal. 
  • We are now working on gaining more exposure internationally, aiming to launch our services in the US as well as other parts of Europe.

Finally, we are proud to announce that we are currently working on a project to physically and literally deliver personalised medicine to the masses, we are now opening an online pharmacy alongside a mobile app, which we aim to launch in the new year.

We have a lot more to cover so please stay tuned to find out more about our future projects!

To stay up to date, please ensure you follow us on Instagram, Twitter, LinkedIn, and Facebook. Also, don't forget to leave us your feedback on Trustpilot and on Google!  

We greatly appreciate your support, early backers! :)

Yours sincerely,


CEO of Rightangled"

Latest Stories

View all

Navigating GLP-1 Medications: Ultimate Guide for the community

Navigating GLP-1 Medications: Ultimate Guide for the community

Dr Sohaib Imtiaz our Clinical Lead and Board certified Lifestyle Medicine Doctor went live with our community. Here are some of the questions we were asked.  As the landscape of weight management medications evolves, questions arise about specific drugs, their...

Read more

Shareholders' letter | Year end 2021 updates - Rightangled

Shareholders' letter | Year end 2021 updates

The copy of an email newsletter sent by CEO Abdullah Sabyah to Rightangled investors on Christmas day (25th of December 2021), the letter covers a full overview and updates from the year-end 2021 with a business outlook to the year 2022.

Read more

Rightangled: Changing the Way We Look at DNA

Rightangled: Changing the Way We Look at DNA

According to the World Health Organisation, cardiovascular diseases (CVD) are the leading cause of deaths worldwide. An estimated 17.7 million people died from CVDs in 2015, representing 31% of all global deaths. In the UK alone, 7 million people battle with CVDs every day. Rightangled...

Read more